Mo. Code Regs. Ann. tit. 20, § 2220-2.410
Class B Hospital Pharmacy Compounding for Drug Shortages
Effective Sep 30, 2023sections 338.140.1 and 338.210, RSMo Supp. 2022, and section 338.280, RSMo 2016.* Original rule filed March 10, 2023, effective Sept. 30, 2023. *Original authority: 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019; 338.210, RSMo 1951, amended 2001, 2011, 2020; and 338.280, RSMo 1951, amended 1971, 1981State Board of Pharmacy
PURPOSE: This rule establishes requirements for Class B hospital pharmacies compounding medication in the event of a drug shortage.
(1) Class B hospital pharmacies may compound and provide medications that are in shortage to patients without a patientspecific prescription, provided—
- (A) The pharmacy has confirmed and documented the product is not available despite due diligence;
- (B) The medication is compounded for administration to patients in a hospital clinic or facility or in another hospital that is under common control, management, or ownership of the same hospital or hospital system, as defined by section 338.165, RSMo;
- (C) The preparation compounded is the same dosage form and strength that is in shortage;
- (D) The quantity distributed at one time does not exceed the amount needed to meet the anticipated healthcare practitioner need for seven (7) days based on the hospital’s or hospital clinic’s/facility’s usage;
- (E) The pharmacy must stop compounding and distribution once the product is available;
(F) The pharmacy must label the preparation container with—
- 1. Pharmacy name, address, and telephone number;
- 2. Date of distribution;
- 3. Preparation name, strength, dosage form, and quantity;
- 4. Name of each active or therapeutic ingredient included
in the preparation;
- 5. Preparation lot/batch number;
- 6. Preparation beyond-use date; and
- 7. Statement: “Pharmacy Compounded Preparation”;
- (G) The pharmacy maintains a record of the distribution that is readily available on request of the board or the board’s authorized designee and can be retrieved by specific hospital or hospital clinic or facility, if requested;
- (H) In lieu of recording an identifying prescription number or a readily retrievable unique identifier, the hospital or hospital clinic or facility name must be recorded on the compounding log;
- (I) The pharmacy must comply with all applicable provisions of 20 CSR 2220-2.400. A Class H license and compliance with 20 CSR 2220-2.200 is required for any sterile preparation; and
- (J) The pharmacy complies with all applicable controlled substance laws and regulations.
- (2) Unless otherwise provided by law or court of competent jurisdiction, the provisions of this rule are only applicable to pharmacy services under the jurisdiction of the board and are not applicable to hospital pharmacy services under the jurisdiction of the Missouri Department of Health and Senior Services pursuant to Chapter 197, RSMo.
AUTHORITY: sections 338.140.1 and 338.210, RSMo Supp. 2022, and section 338.280, RSMo 2016.* Original rule filed March 10, 2023, effective Sept. 30, 2023. *Original authority: 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019; 338.210, RSMo 1951, amended 2001, 2011, 2020; and 338.280, RSMo 1951, amended 1971, 1981.